Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Phase Distribution

Ph not_applicable

25%

Ph phase_4

50%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

2(50.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(2)

Detailed Status

Completed2

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (25.0%)

Phase 42 (50.0%)

N/A1 (25.0%)

Trials by Status

completed250%

unknown250%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_4

Comparison of Optimal Hypertension Regimens

NCT02847338

unknownnot_applicable

Skin Sodium and Salt Sensitivity of Blood Pressure

NCT05976438

completedphase_2

The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.

NCT04393493

unknownphase_4

Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD

NCT02502981

Clinical Trials (4)

Showing 4 of 4 trials

NCT02847338Phase 4

Comparison of Optimal Hypertension Regimens

Completed

NCT05976438Not Applicable

Skin Sodium and Salt Sensitivity of Blood Pressure

Unknown

NCT04393493Phase 2

The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.

Completed

NCT02502981Phase 4

Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4